English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

Synthesis of a potent photoreactive acidic γ-secretase modulator for target identification in cells.

MPS-Authors
/persons/resource/persons182759

Rennhack,  Andreas
Research Group Chemical Biology of Neurodegenerative Diseases, Center of Advanced European Studies and Research, ;
Department of Molecular Sensory Systems, Center of Advanced European Studies and Research (caesar), Max Planck Society;

Bulic,  Bruno
Research Group Chemical Biology of Neurodegenerative Diseases, Center of Advanced European Studies and Research, ;
Department of Molecular Sensory Systems, Center of Advanced European Studies and Research (caesar), Max Planck Society;

Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)
There is no public supplementary material available
Citation

Rennhack, A., Jumpertz, T., Ness, J., Baches, S., Pietrzik, C. U., & Bulic, B. (2012). Synthesis of a potent photoreactive acidic γ-secretase modulator for target identification in cells. Bioorganic & Medicinal Chemistry, 20(21), 6523-6532. doi:doi.org/10.1016/j.bmc.2012.08.034.


Cite as: https://hdl.handle.net/21.11116/0000-0003-A521-D
Abstract
Supramolecular self-assembly of amyloidogenic peptides is closely associated with numerous pathological conditions. For instance, Alzheimer´s disease (AD) is characterized by abundant amyloid plaques originating from the proteolytic cleavage of the amyloid precursor protein (APP) by β- and γ-secretases. Compounds named γ-secretase modulators (GSMs) can shift the substrate cleavage specificity of γ-secretase toward the production of non-amyloidogenic, shorter Aβ fragments. Herein, we describe the synthesis of highly potent acidic GSMs, equipped with a photoreactive diazirine moiety for photoaffinity labeling. The probes labeled the N-terminal fragment of presenilin (the catalytic subunit of γ-secretase), supporting a mode of action involving binding to γ-secretase. This fundamental step toward the elucidation of the molecular mechanism governing the GSM-induced shift in γ-secretase proteolytic specificity should pave the way for the development of improved drugs against AD.